Comprehensive cardiovascular, renal and metabolism (cvrm) operations including research, development, and commercialization activities. This segment focuses on innovative approaches and solutions within the cardiovascular, renal and metabolism (cvrm) field, leveraging advanced technologies and expertise to address unmet medical needs and improve patient outcomes.

Specialized oncology research and development focusing on cancer therapeutics, precision medicine, and targeted therapies. This segment includes immunotherapy, chemotherapy, and novel cancer treatment approaches.

Comprehensive respiratory & immunology operations including research, development, and commercialization activities. This segment focuses on innovative approaches and solutions within the respiratory & immunology field, leveraging advanced technologies and expertise to address unmet medical needs and improve patient outcomes.

Dedicated rare disease research and orphan drug development addressing unmet medical needs. This segment focuses on genetic disorders, rare cancers, and conditions affecting small patient populations.